Related Experiment Video

Updated: Jul 4, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Herpes simplex virus NV1020 as a novel and promising therapy for hepatic malignancy

Kaitlyn J Kelly1, Joyce Wong, Yuman Fong

  • 1Memorial Sloan-Kettering Cancer Center, Department of Surgery, 1275 York Avenue, New York, NY 10065, USA.

Expert Opinion on Investigational Drugs
|June 14, 2008
PubMed
Abstract

Insights

NV1020, an oncolytic herpes simplex virus, shows promise as a safe and effective treatment for hepatic malignancy. This novel agent offers a potential new therapy for patients with refractory liver cancer.

Area of Science:

  • Oncolytic virotherapy
  • Hepatobiliary oncology

Background:

  • Hepatic malignancy carries a poor prognosis with conventional treatments.
  • Oncolytic viruses represent a novel therapeutic strategy.
  • NV1020 is an oncolytic herpes simplex virus with potential for liver cancer treatment.

Purpose of the Study:

  • To review the development of NV1020 as an oncolytic agent.
  • To explore the role of NV1020 in treating human hepatic cancer.

Main Methods:

  • Review of preclinical data for NV1020.
  • Examination of current and emerging liver cancer therapies.
  • Focus on NV1020's safety and clinical efficacy in hepatic malignancy.

Main Results:

  • NV1020 demonstrated preclinical efficacy against hepatic malignancy.
  • The agent was evaluated for its safety profile in relevant models.

Conclusions:

  • NV1020 is a safe and novel therapeutic agent.
  • It offers a potential treatment option for refractory hepatic malignancy.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus06:14

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus

Published on: May 13, 2021

Related Concept Videos

Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...